[Webinar]: 3D Bioprinting Complex Tissue Models for Drug Screening
For the fourth installment of our webinar series, we welcomed a member of our Discovery Ecosystem: Dr. Stephanie Willerth, Professor and Canada Research Chair in Biomedical Engineering at the University of Victoria. The Willerth lab focuses on innovative strategies for engineering neural tissue.
This talk covered recent work from the Willerth lab on developing 3D tissue models using microfluidic 3D bioprinting. It also discussed how these bioprinted constructs containing multiple cell types could be an important tool in drug screening.
Presenter - Stephanie Willerth, PHD
Professor and Canada Research Chair, Biomedical Engineering, University of Victoria
Dr. Willerth, a Full Professor in Biomedical Engineering, holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences. She also holds an appointment with the School of Biomedical Engineering at the University of British Columbia. She serves as the Acting Director of the Centre for Biomedical Research and the Biomedical Engineering undergraduate program at the University of Victoria. She is an active member of the steering committee of the B.C. Regenerative Medicine Initiative and the Stem Cell Network. She also serves as a staff scientist at Creative Destruction Lab. She is the co-founder of the start-up Axolotl Biosciences.
Learn more about the Willerth lab here.